A Japanese pharma company this Monday reported that the drug ivermectin, which is used to fight parasites, reveals an “antiviral effect” on Omicron and other covid variants in a study.
Kowa Company, Ltd. who is partnered with Kitasato University in Japan in a joint lab study that researched at ivermectin as a possible treatment for COVID-19, Reuters says. The company stated in a media release that trials for the study are still going on.
The use of ivermectin to deal with COVID-19 is very controversial. A 2020 study discovered that the drug seemed to have antiviral effects against the virus in vitro, colloquially meaning “test tubes.” Those early results caused hope that ivermectin might be developed into an effective solution for COVID-19, but clinical studies with patients considered by the United States government did not show the drug was effective at dealing with COVID-19.
An investigative report discovered over a third of 26 trials with ivermectin being used for COVID-19 had “serious signs of possible fraud,” and that the rest of the studies did not reveal it worked as a treatment for COVID-19.
Kowa’s media release confirms that ivermectin has antiviral effects against the Omicron variant in experiments as it was previously shown to have with other covid variants.
Ivermectin is not accepted for use against coronavirus in Japan, and the U.S. FDA has repeatedly warned against using it as a COVID-19 therapeutic. The WHO, the EU drug regulator, and Merck, the maker of ivermectin, have also warned on its use.
But many doctors advocate for a right to try ivermectin because of the evidence that it works.
When popular podcaster Joe Rogan got COVID last fall, he said he took “all sorts of meds” to treat his illness, including monoclonal antibodies and ivermectin. After he got better, Rogan was derided by the media and falsely said to be taking “horse dewormer.”
While there is an ivermectin paste now available for animals, there is also a human version of the medication, and that is the medicine that Rogan took.